¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"total gain"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® total lung capacity ÇÑ±Û ÀüÆó¿ë·®, ¿ÂÇãÆÄ¿ë·®
¼³¸í   
  ÆóȰ·®(°¡´ÉÇÑ ÇÑ ±í°Ô µé¿© ¸¶½Å ½ÃÁ¡ºÎÅ͠õõÈ÷ ÇѲ¯ ³»½® ¿ë·®)¿¡ Àܱⷮ(ÃÖ´ë ³¯¼ûÀ§Ä¡¿¡¼­ Æó³»¿¡ ³²Àº ¿ë·®. ¾à 1,200mL)À» ÇÕÇÑ °ÍÀÌ´Ù. °Ç°­ÇÑ ¼ºÀÎÀº 6,000~7,000mL. Æó±âÁ¾, ¸¸¼º ±â°üÁö¿° µîÀÇ Æó»ö¼º Àå¾Ö·Î Áõ°¡ÇϰԠµÇ´Â ÇÑÆí ÇãÆÄ¼¶À¯Áõ, ¹«±âÆó, Èä¼ö, Èä°ûº¯Çü µîÀÇ ±¸¼Ó¼º Àå¾Ö·Î °¨¼ÒÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • extended radical total gastrectomy
    È®´ë±ÙÄ¡ÀüüÀ§ÀýÁ¦(¼ú)
  • radical total gastrectomy
    ±ÙÄ¡ÀüüÀ§ÀýÁ¦(¼ú)
  • acoustic gain
    À½ÇâÁõÆø
  • gain
    1. ȹµæ, À̵æ 2. Áõ°¡ 3. ÁõÆø
  • oxygen gain factor
    »ê¼ÒÀ̵æ°è¼ö
  • weight gain
    üÁßÁõ°¡
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • gain
    ȹµæ, À̵æ, Áõ°¡, ÁõÆø
  • total androgen
    ÃѾȵå·Î°Õ
  • total iron binding capacity
    ÃÑö°áÇÕ´É
  • total lung capacity
    ÃÑÆó¿ë·®, ¿ÂÇãÆÄ¿ë·®
  • extended radical total gastrectomy
    È®´ë±ÙÄ¡ÀüüÀ§ÀýÁ¦¼ú
  • radical total gastrectomy
    ±ÙÄ¡ÀüüÀ§ÀýÁ¦¼ú
  • total gastrectomy
    ÀüüÀ§ÀýÁ¦¼ú
  • total abdominal hysterectomy
    ¹èÀüüÀÚ±ÃÀýÁ¦¼ú, º¹½ÄÀüüÀÚ±ÃÀýÁ¦¼ú
  • total parenteral nutrition
    ¿ÏÀüºñ°æ±¸¿µ¾ç¹ý
  • total proctocolectomy
    ÀüüūâÀÚÀýÁ¦¼ú, Àüü´ëÀåÀýÁ¦¼ú, ūâÀÚÀüüÀýÁ¦¼ú, ´ëÀåÀüüÀýÁ¦¼ú
  • total pulmonary resistance
    ÆóÇ÷°üÀúÇ×, ÇãÆÄÇ÷°üÀúÇ×
  • total volume urine
    Ãѹ财·®
  • total body water
    ÃÑü¾×·®
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acoustic gain
    À½ÇâÁõÆø
  • oxygen gain factor
    »ê¼ÒÀ̵æ°è¼ö
  • therapeutic gain factor
    Ä¡·áÀ̵æ°è¼ö
  • gain
    ȹµæ, À̵æ, Áõ°¡, ÁõÆø
  • weight gain
    üÁßÁõ°¡
  • total albinism
    ¿Â¹é»öÁõ
  • total ankylosis
    ¿ÏÀü°­Á÷, ¿ÏÀü°üÀý±»À½Áõ
  • total anodontia
    ¿ÏÀü¹«Ä¡¾ÆÁõ
  • total aphasia
    (¢¡global aphasia) ¿ÏÀü¾ð¾î»ó½ÇÁõ
  • total blindness
    ¿ÏÀü½Ã°¢»ó½Ç, ¿ÏÀü½Ç¸í
  • total color blindness
    ¿ÏÀü»ö°¢»ó½Ç, ¿ÏÀü»ö¸Í
  • total cataract
    ¿ÏÀü¹é³»Àå
  • total cleavage
    (¢¡holoblastic cleavage) ¿ÂºÐÇÒ, ÀüüºÐÇÒ
  • total cystectomy
    ¹æ±¤¸ðµÎÀýÁ¦¼ú
  • total bacterial count
    Ãѱռö
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • TIBC => total iron binding capacity
    ÃÑö°áÇÕ´É
  • TLC => total lung capacity
    ÀüÆó¿ë·®
  • TORP [=total ossicular replacement prosthesis]
    ÀüÀ̼Ұñ´ëÄ¡¹°
  • holoblastic cleavage total cleavage
    ÀüüºÐÇÒ
  • AGC (automatic gain control)
    ÀÚµ¿ °ÔÀÎ Á¶Àý
  • AGC (automatic gain control)
    ÀÚµ¿ (í»ÔÑ) °ÔÀÎ Á¶Àý (ðàï½), À̵æÀÚµ¿Á¶Àý
  • T.G.C (time gain compensation)
    ½Ã°£ (ãÁÊà) °ÔÀÎ º¸»ó (ÜÍßÁ), °Å¸®(±íÀÌ) °ÔÀÎ º¸»ó
  • T.G.C (time gain compensation)
    ½Ã°£ °ÔÀÎ º¸»ó
  • acoustic gain
    À½Çâ ÁõÆø
  • gain
    °ÔÀÎ
  • primary gain
    ÀÏÂ÷(Àû) À̵æ(ìéó­îÜì¦Ôð).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • total gain
    ÃÑ (õÅ) °ÔÀÎ
  • total gain
    ÃÑ °ÔÀÎ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • total parenteral nutrition, total
    ÃÑüÀû ºñ°æ±¸Àû ¿µ¾ç¼·Ãë
  • acoustic gain
    À½Çâ ÁõÆø
  • depth gain compensation
    ±íÀÌ °ÔÀÎ(°­µµ) º¸»ó
  • far gain
    ¿ø°Å¸® °ÔÀÎ
  • far gain
    ¿ø°Å¸® (êÀËå×î) °ÔÀÎ
  • gain
    °ÔÀÎ
  • near gain
    ±Ù°Å¸® °ÔÀÎ
  • near gain
    ±Ù°Å¸® (ÐÎËå×î) °ÔÀÎ
  • oxygen gain factor (OGF)
    »ê¼ÒÀ̵æ°è¼ö
  • primary gain
    ÀÏÂ÷(Àû) À̵æ(ìéó­îÜì¦Ôð).
  • secondary gain
    ÀÌÂ÷¼º À̵æ
  • secondary gain
    ÀÌÂ÷(Àû) À̵æ(¡­ì¦Ôð).
  • therapeutic gain factor, TGF
    Ä¡·áÀ̵æ°è¼ö
  • time gain compensation
    ½Ã°£ (ãÁÊà) °ÔÀÎ º¸»ó (ÜÍßÁ)
  • time gain compensation
    ½Ã°£ °ÔÀÎ º¸»ó
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Total organism duplication
    °³Ã¼Áߺ¹
    [¿¾ ¿ë¾î] °³Ã¼Áߺ¹
  • Total hyperplasia (Macrodactylia)
    Àüü°ú´ÙÇü¼º (Å«¼Õ°¡¶ôÁõ)
    [¿¾ ¿ë¾î] ÀüüÀû°ÅÀÎÁõ
  • Total organ duplication (Double ureter)
    Àüü±â°üÁߺ¹ (°ã¿ä°ü)
    [¿¾ ¿ë¾î] Àüü±â°üÁߺ¹ (°ã¿ä°ü)
  • Holoblastic cleavage [Total cleavage]
    ÀüüºÐÇÒ
    [¿¾ ¿ë¾î] Àü³­ÇÒ
  • Total heart defect
    Àüü½ÉÀå°áÇÔ
    [¿¾ ¿ë¾î] ½ÉÀåÀü°áÇÔ
  • Total abnormal shape
    ÀüüÀÌ»óÇüÅÂ
    [¿¾ ¿ë¾î] ÀüüÀûÀÌ»óÇü
  • Total inversion (Situs inversus)
    ÀüüÀÚ¸®¹Ù²Þ (¿Â³»ÀåÀÚ¸®¹Ù²Þ)
    [¿¾ ¿ë¾î] ÀüüÀû¿ªÀ§
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antigenic gain
    Ç׿ø¼º Áõ°¡(ù÷ê«àõñòÊ¥)
  • GaIN
    (å²) galactosamine
  • total inhibition
    ÀüÀúÇØ(îïîÁúª)
  • total iron-binding capacity
    ÃÑö°áÇÕ´É (õÅôÑÌ¿ùêÒö)
  • total osmotic pressure
    ÃÑ»ïÅõ¾Ð (õÅß¶÷âäâ)
  • total titer
    ÃÑ¿ª°¡ (õÅæ³Ê¤)
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • total gain
    ÃѰÔÀÎ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • total
    ÀüüÀÇ, ¿ÏÀüÀÇ
  • total body opacification
    Àü½ÅºÒÅõ¸íÈ­
  • AGC [=automatic gain control]
    ÀÚµ¿°ÔÀÎÁ¶Àý
  • depth gain compensation
    ±íÀ̰ÔÀÎ(°­µµ)º¸»ó
  • far gain
    ¿ø°Å¸®°ÔÀÎ
  • gain
    °ÔÀÎ
  • near gain
    ±Ù°Å¸®°ÔÀÎ
  • T.G.C [=time gain compensation]
    ½Ã°£°ÔÀκ¸»ó
  • time gain compensation [=T.G.C.]
    ½Ã°£°ÔÀκ¸»ó
  • time gain compenstaion curve
    ½Ã°£°ÔÀκ¸»ó°î¼±
  • time gain control
    ½Ã°£°ÔÀÎÁ¶Àý
  • weight gain
    üÁßÁõ°¡
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
TC target cell; taurocholate; temperature compensation; teratocarcinoma; tertiary cleavage; tetracyclin...
TBS total body solids; total body solute; total body surface; total burn size; Townes-Brocks syndrome; t...
TLC tender loving care; thin-layer chromatography; total L-chain concentration; total lung capacity; tot...
AGC Automatic Gain Control
AGC absolute granulocyte count; automatic gain control
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AGC Automatic Gain Control
ADG Average daily gain
BWG Body weight gain
G Gain
gf Gain-of-function
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • near gain
    ±Ù°Å¸® °ÔÀÎ
  • organ gain access
    ±âÁú À̵æ Á¢±Ù
  • primary gain
    ÀÏÂ÷ À̵æ
  • secondary gain
    ÀÌÂ÷ À̵æ
    °£Á¢ÀûÀÎ À̵æÀ¸·Î¼­ º¸Åë Áúº´À̳ª ¼è¾àÀ¸·ÎºÎÅÍ ¾ò¾îÁø´Ù. À̰ÍÀº Àڽſ¡°Ô ÇØ·Î¿î Àǹ«³ª Ȱµ¿À» ÇÇÇϰí Åë»óÀûÀ¸·Î´Â µµ¿ÍÁÖÁö ¾Ê´Â »ç¶÷À¸·ÎºÎÅÍ ÁöÁö¸¦ ¹ÞÀ» ¼ö ÀÖµµ·Ï ÇÑ´Ù.
  • time gain compensation
    ½Ã°£ °ÔÀÎ º¸»ó
  • time gain control
    ½Ã°£ °ÔÀÎ Á¶Àý
  • weight gain
    üÁß Áõ°¡
    °ú´ÙÇÑ À½½ÄÀÇ ¼·Ãë, ¿îµ¿À¸·Î ÀÎÇÑ ±ÙÀ°ÀÇ Áõ°¡, º´Àû »óȲ µîÀÇ ¿øÀÎÀÌ ÀÖÀ¸³ª º¸Åë °ú½ÄÀ¸·Î ÀÎÇÑ Ã¼Áö¹æÀÇ Áõ°¡ ¶Ç´Â º´À¸·Î ÀÎÇÑ Ã¼ÁßÁõ°¡ µîÀÇ ¶æÀ¸·Î ³ª»Ú°Ô ¾²ÀδÙ.
  • total
    ¿ÏÀü, ÀüüÀÇ, ¿ÏÀüÀÇ
  • total abduction
    ¿ÏÀü ¿ÜÀü, Àü°³»ê·Â
  • total acid phosphatase
    Ãѻ꼺 ÀÎ»ê ºÐÇØ È¿¼Ò, Ãѻ꼺 Æ÷½ºÆÄŸÁ¦
  • total albinism
    ¿Â¹é»öÁõ
  • total ankylosis
    ¿ÏÀü °­Á÷
    ±ÙÀ° µî¿¡ ÀüüÀûÀ̰í ÃÑüÀûÀ¸·Î ¿Â °­Á÷ Çö»ó.
  • total anomalous pulmonary venous connection
    ÀüÆó Á¤¸Æ ¿¬°á ÀÌ»ó, ÃÑ Æó Á¤¸Æ ȯ·ù ÀÌ»ó, Æó Á¤¸Æ ¿¬°á ÀÌ»ó
    1. Á¿ìÀÇ ¸ðµç Æó Á¤¸ÆµéÀÌ Á½ɹæ°ú ¿¬°áµÇÁö ¾Ê°í ºñÁ¤»óÀûÀÎ °æ·Î¸¦ °ÅÃÄ Ã¼Á¤¸ÆÀ¸·Î ¿¬°áµÇ´Â °Í. ȯÀÚ°¡ »ýÁ¸Çϱâ À§Çؼ­´Â ¹Ýµå½Ã ½É¹æ Áß°Ý °á¼ÕÁõÀÌ ÀÖ¾î¾ß ÇÏ¸ç Æó Á¤¸ÆÀÌ ¿¬°áµÇ´Â ºÎÀ§¿¡ µû¶ó ½ÉÀå »óºÎÇü
  • total aphasia
    Àü½Ç¾îÁõ
  • total blindness
    ¿ÏÀü ¸Í, ¿ÏÀü ½Ç¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
gain <physics> (Amplification) Increase in a signal transmitted from one point to another through an amplifier.
(09 Oct 1997)
weight gain Increase in body weight over existing weight.
(12 Dec 1998)
primary gain Interpersonal, social, or financial advantages from the conversion of emotional stress directly into demonstrably organic illnesses (e.g., hysterical blindness or paralysis).
Compare: secondary gain.
(05 Mar 2000)
secondary gain Interpersonal or social advantages (e.g., assistance, attention, sympathy) gained indirectly from organic illness.
Compare: primary gain.
(05 Mar 2000)
time-compensated gain In ultrasonography, an increase in receiver gain with time to compensate for loss in echo amplitude with depth, usually due to attenuation.
Synonym: attenuation compensation, depth compensation, time compensation gain, time-compensated gain, time-varied gain control, time-varied gain.
(05 Mar 2000)
time compensation gain In ultrasonography, an increase in receiver gain with time to compensate for loss in echo amplitude with depth, usually due to attenuation.
Synonym: attenuation compensation, depth compensation, time compensation gain, time-compensated gain, time-varied gain control, time-varied gain.
(05 Mar 2000)
time-gain compensation In ultrasonography, an increase in receiver gain with time to compensate for loss in echo amplitude with depth, usually due to attenuation.
Synonym: attenuation compensation, depth compensation, time compensation gain, time-compensated gain, time-varied gain control, time-varied gain.
(05 Mar 2000)
time-varied gain In ultrasonography, an increase in receiver gain with time to compensate for loss in echo amplitude with depth, usually due to attenuation.
Synonym: attenuation compensation, depth compensation, time compensation gain, time-compensated gain, time-varied gain control, time-varied gain.
(05 Mar 2000)
time-varied gain control In ultrasonography, an increase in receiver gain with time to compensate for loss in echo amplitude with depth, usually due to attenuation.
Synonym: attenuation compensation, depth compensation, time compensation gain, time-compensated gain, time-varied gain control, time-varied gain.
(05 Mar 2000)
radical mastectomy, total Breast cancer treatment involving removal of the breast, the pectoral (chest) muscles, lymph nodes (the glands ) in the armpit and associated skin and subcutaneous tissue.
(12 Dec 1998)
parenteral nutrition, home total The at-home administering of nutrients for assimilation and utilization by a patient whose sole source of nutrients is via solutions administered intravenously, subcutaneously or by some other non-alimentary route.
(12 Dec 1998)
parenteral nutrition, total The delivery of nutrients for assimilation and utilization by a patient whose sole source of nutrients is via solutions administered intravenously, subcutaneously, or by some other non-alimentary route. The basic components of tpn solutions are protein hydrolysates or free amino acid mixtures, monosaccharides, and electrolytes. Components are selected for their ability to reverse catabolism, promote anabolism, and build structural proteins.
(12 Dec 1998)
reversal of organs, total This condition (medically called situs inversus totalis) involves complete transposition (right to left reversal) of the thoracic and abdominal organs. The heart is not in its usual position in the left chest but is on the right. Specifically related to the heart, this is referred to as dextrocardia (literally, right-hearted). And the stomach, which is normally in the left upper abdomen, is on the right. In patients with situs inversus totalis, all of the chest and abdominal organs are reversed and appear in mirror image when examined or visualised by tests such as X-ray filming. Situs inversus totalis has been estimated to occur once in about 6-8,000 births. Situs inversus occurs in a rare abnormal condition that is present at birth (congenital) called kartagener's syndrome.
(12 Dec 1998)
communication methods, total Utilization of all available receptive and expressive modes for the purpose of achieving communication with the hearing impaired, such as gestures, postures, facial expression, types of voice, formal speech and non-speech systems, and simultaneous communication.
(12 Dec 1998)
congenital total lipodystrophy Lipodystrophy characterised by almost complete lack of subcutaneous fat, accelerated rate of growth and skeletal development during the first 3 to 4 years of life, muscular hypertrophy, cardiac enlargement, hepatosplenomegaly, hypertrichosis, renal enlargement, hypertriglyceridemia, and hypermetabolism; both autosomal dominant and X-linked varieties exist.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • gain
    ¾ò´Ù,ȹµæÇÏ´Ù,-¿¡ µµ´ÞÇÏ´Ù
  • gain on
    -À» ´É°¡ÇÏ´Ù
  • total
    ÀüüÀÇ
  • capital gain
    ÀÚº» ÀÌÀÍ;°íÁ¤ ÀÚ»ê ¸Å°¢¼Òµæ
  • gain
    ÀÌÀÍ;Áõ°¡;Áøº¸;(pl) À̵æ;¹úÀÌ
  • gain
    ÀÌÀÍÀ» ¾ò´Ù;³ª¾Æ°¡´Ù;ÀߵǴÙ;~ (up)on ~¿¡ Á¢±ÙÇÏ´Ù;(¾Æ¹«¿¡°Ô) ºô ºÙ´Ù;~¿¡ ħ½ÄÇÏ´Ù;~ over ¼³º¹½ÃŰ´Ù;(ÀÚ±â ÆíÀ¸·Î)²ø¾îµéÀÌ´Ù
  • gain
    ¾ò´Ù;À̱â´Ù;ȹµæÇÏ´Ù;(¹«°Ô,Èû µîÀÌ)´Ã´Ù;(½Ã°è°¡)´õ °¡´Ù
  • gain control
    (ÀüÀÚ)(¼ö½Å±â,Á߯ø±âÀÇ)À̵æ Á¦¾î
  • grand total
    ÃѰè
  • total
    Àüü(ÀÇ);ÇÕ°è(ÀÇ);¿ÏÀüÇÑ(a ~ failure)
  • total
    ÇÕ°èÇÏ´Ù;ÇÕ°è...ÀÌ µÇ´Ù
  • total abstanince
    Àý´ë±ÝÁÖ
  • total abstaniner
    Àý´ë±ÝÁÖ°¡
  • total war (warfare)
    ÃÑ·ÂÀü 
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á